Inflammatory Marker Analysis in Psoriatic Skin Under topical Phospodiesterase 4 Inhibitor Treatment
Topical formulations of the two PDE4i roflumilast and TAK-084 lead to a reduction of inflammatory markers and infiltrating cells in psoriatic lesional skin.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου